Rite Aid Expands No-Charge COVID-19 Testing to 460 Drive-Through Locations
January 21 2021 - 10:00AM
Business Wire
Self-Swab Testing Now Available for Ages
Four and Older
Rite Aid (NYSE: RAD) is further expanding its no-charge COVID-19
testing capabilities with 60 additional drive-through locations
opening on Friday, January 22, through its partnership with the
U.S. Department of Health and Human Services (HHS).
Additionally, no-charge testing will now be available for ages
four and older at all new and existing drive-through testing sites.
Previously, testing had been available to individuals 13 years of
age and older. The new locations will increase Rite Aid's capacity
for COVID-19 testing services in California, Washington, Michigan,
Ohio, Pennsylvania, Virginia, New York, Massachusetts, New Jersey
and Maryland.
Like Rite Aid's existing drive-through testing sites, the new
locations will utilize simple self-swab nasal tests overseen by
Rite Aid pharmacists and will operate Monday through Friday 10 a.m.
- 8 p.m. and Saturday and Sunday 10 a.m. - 5 p.m. Rite Aid's
COVID-19 nasal tests are available for all individuals four years
of age and older, regardless if they are experiencing virus
symptoms, in accordance with the Centers for Disease Control and
Prevention (CDC) guidance.
At all testing locations, patients are required to pre-register
online at www.riteaid.com in order to schedule a time slot for
testing. Individuals ages 4-18 may access testing with parent or
legal guardian consent, and attendance and supervision of the minor
at the testing appointment with a photo ID. For children ages 4-12,
a parent or legal guardian will create a Project Baseline account
and follow the steps to indicate who the test is for. For children
ages 13-17, creation of a Project Baseline account should happen
only under the supervision of a parent or legal guardian.
A complete list of Rite Aid's COVID-19 testing sites can also be
found at www.riteaid.com.
Rite Aid partners with Verily and its Baseline COVID-19 Testing
Program to provide screening, scheduling and return of results to
participants for Rite Aid testing sites.
BioReference Laboratories provides COVID-19 laboratory
testing.
Clinical oversight for the COVID-19 testing program is provided
by PWNHealth, a national clinician network that enables safe and
easy access to diagnostic testing.
Rite Aid will continue to provide regular updates on the
company's progress with COVID-19 testing.
About Rite Aid Corporation
Rite Aid Corporation is on the front lines of delivering
healthcare services and retail products to more than 1.6 million
Americans daily. Our pharmacists are uniquely positioned to engage
with customers and improve their health outcomes. We provide an
array of whole being health products and services for the entire
family through over 2,400 retail pharmacy locations across 17
states. Through Elixir, we provide pharmacy benefits and services
to approximately 4 million members nationwide. For more
information, www.riteaid.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20210121005043/en/
MEDIA: Chris Savarese 717-975-5718
christopher.savarese@riteaid.com
Rite Aid (NYSE:RAD)
Historical Stock Chart
From Mar 2024 to Apr 2024
Rite Aid (NYSE:RAD)
Historical Stock Chart
From Apr 2023 to Apr 2024